Pacira | Despesas Operacionais





Despesas Operacionais Alterar Data
Assertio Holdings USD 105.8M 12.5M 2025-09
Astellas Pharma JPY 436.66B 16.75B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Cara Therapeutics USD 4.96M 2.38M 2025-03
Coherus Biosciences USD 53.03M 43.41M 2025-03
Heron Therapeutics USD 38.47M 4M 2024-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.97B 2.38B 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novo Nordisk DKK 46.76B 3.99B 2025-12
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 166.36M 4.5M 2025-09
Perrigo USD 949.9M 50.8M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Supernus Pharmaceuticals USD 252.29M 98.98M 2025-09
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Xeris Pharmaceuticals USD 67.65M 590K 2025-09
Xoma USD 22.84M 1.67M 2024-09
Zoetis USD 1.55B 3.85B 2025-12


Pacira Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.